Read + Share
Amedeo Smart
Independent Medical Education
Sica M, Barone F, Nannelli C, Ricci P, et al. The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab. Br J Haematol 2023;201:e1-e4.PMID: 36660816
Email
LinkedIn
Facebook
Twitter
Privacy Policy